Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Portfolio update – Diraq

22nd May 2026 11:02

RNS Number : 4826F
UIL Limited
22 May 2026
 

22 May 2026

UIL LIMITED

(LEI Number: 213800CTZ7TEIE7YM468)

Portfolio update - Diraq

The Board of UIL Limited ("UIL" or the "Company") is pleased to announce that its investee company Diraq Pty Ltd ("Diraq") has signed a Letter of Intent (LOI) with the U.S. Department of Commerce for up to $38 million in proposed federal funding from the CHIPS Research and Development Office. This award will support production and scaling of fault-tolerant silicon quantum computing processors via the U.S. semiconductor industry.

Diraq is pioneering the use of silicon-based quantum processors, which have the ability to contain millions of qubits on a single chip, and are fabricated with existing semiconductor manufacturing processes. This investment will accelerate Diraq's roadmap to enable an end-to-end quantum supply chain. Founded in Sydney, Australia, Diraq has U.S. offices and labs in Palo Alto and Chicago, and will soon open a significant new operation in Los Angeles. The company is growing its team and business in the United States and is actively working with domestic partners to further accelerate the U.S. quantum ecosystem

UIL's investment in Diraq is through Allectus Quantum Holdings Limited, an investment holding company for quantum technology investments with its current portfolio comprising only an investment in Diraq. As at 30 April 2026, Allectus Quantum Holdings Limited represented 8.4% of UIL's investment portfolio.

 

 

Name of contact and telephone number for enquiries:

 

Charles Jillings

ICM Investment Management Limited

Telephone: 01372 271486

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUKLLBLQELEBBK

Related Shares:

UtilUil Fin Zdp 26
FTSE 100 Latest
Value10,466.26
Change22.79